Found: 287
Select item for more details and to access through your institution.
Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia.
- Published in:
- CNS Drugs, 2024, v. 38, n. 7, p. 559, doi. 10.1007/s40263-024-01089-w
- By:
- Publication type:
- Article
The Relationship between Patient Self-Reported, Pre-Morbid Physical Activity and Clinical Outcomes of Inpatient Treatment in Youth with Anorexia Nervosa: A Pilot Study.
- Published in:
- Nutrients, 2024, v. 16, n. 12, p. 1889, doi. 10.3390/nu16121889
- By:
- Publication type:
- Article
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2024, p. 1, doi. 10.1177/20451253241257062
- By:
- Publication type:
- Article
Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 6, p. 772, doi. 10.3390/pharmaceutics16060772
- By:
- Publication type:
- Article
On the Road to Individualizing Pharmacotherapy for Adolescents and Adults with Schizophrenia – Results from an Expert Consensus Following the Delphi Method.
- Published in:
- Neuropsychiatric Disease & Treatment, 2024, v. 20, p. 1139, doi. 10.2147/NDT.S456163
- By:
- Publication type:
- Article
Premorbid body weight predicts weight loss in both anorexia nervosa and atypical anorexia nervosa: Further support for a single underlying disorder.
- Published in:
- International Journal of Eating Disorders, 2024, v. 57, n. 4, p. 967, doi. 10.1002/eat.24189
- By:
- Publication type:
- Article
Severe mental illness: cardiovascular risk assessment and management.
- Published in:
- European Heart Journal, 2024, v. 45, n. 12, p. 987, doi. 10.1093/eurheartj/ehae054
- By:
- Publication type:
- Article
Development and Validation of a Machine Learning–Based Model of Mortality Risk in First-Episode Psychosis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e240640, doi. 10.1001/jamanetworkopen.2024.0640
- By:
- Publication type:
- Article
Wirksamkeit in Deutschland verfügbarer internetbasierter Interventionen für Depressionen – ein systematisches Review mit Metaanalyse.
- Published in:
- Der Nervenarzt, 2024, v. 95, n. 3, p. 206, doi. 10.1007/s00115-023-01587-0
- By:
- Publication type:
- Article
Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 3, p. 299, doi. 10.1164/rccm.202308-1525OC
- By:
- Publication type:
- Article
Comparing family‐based treatment with inpatient treatment in youth with anorexia nervosa eligible for hospitalization: A 12‐month feasibility study.
- Published in:
- International Journal of Eating Disorders, 2024, v. 57, n. 2, p. 388, doi. 10.1002/eat.24098
- By:
- Publication type:
- Article
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations.
- Published in:
- International Journal of Neuropsychopharmacology, 2024, v. 27, n. 2, p. 1, doi. 10.1093/ijnp/pyad067
- By:
- Publication type:
- Article
Pharmacologic Treatment of Schizophrenia Beyond Dopamine Receptor Blockade—Has Its Time Come Yet?
- Published in:
- JAMA Psychiatry, 2024, v. 81, n. 2, p. 118, doi. 10.1001/jamapsychiatry.2023.4353
- By:
- Publication type:
- Article
Do psychotic experiences act as effect modifiers in youths with common mental health problems allocated to transdiagnostic cognitive behavioural therapy versus management as usual? Secondary analyses of the Mind‐My‐Mind randomized trial.
- Published in:
- Early Intervention in Psychiatry, 2024, v. 18, n. 1, p. 26, doi. 10.1111/eip.13423
- By:
- Publication type:
- Article
Alternative Approaches for Addressing Acute Agitation in Schizophrenia and Bipolar Disorder.
- Published in:
- Primary Care Companion for CNS Disorders (2155-7772), 2024, v. 26, n. 1, p. e1, doi. 10.4088/PCC.23nr03596
- By:
- Publication type:
- Article
Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning.
- Published in:
- Schizophrenia (2754-6993), 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41537-023-00420-6
- By:
- Publication type:
- Article
Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2023, p. 1, doi. 10.1177/20451253231211575
- By:
- Publication type:
- Article
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis.
- Published in:
- JAMA Psychiatry, 2023, v. 80, n. 12, p. 1196, doi. 10.1001/jamapsychiatry.2023.2983
- By:
- Publication type:
- Article
Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly.
- Published in:
- Schizophrenia (2754-6993), 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41537-023-00405-5
- By:
- Publication type:
- Article
Assessment and Diagnostic Classification Using DC:0-5 in Early Childhood Mental Health Clinics: The Protocol for the Developmental Psychiatry Diagnostic Challenges Study (DePsy).
- Published in:
- Children, 2023, v. 10, n. 11, p. 1770, doi. 10.3390/children10111770
- By:
- Publication type:
- Article
Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomes.
- Published in:
- BMC Psychiatry, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12888-023-05230-9
- By:
- Publication type:
- Article
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2023, p. 1, doi. 10.1177/20451253231200258
- By:
- Publication type:
- Article
Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study.
- Published in:
- Schizophrenia (2754-6993), 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41537-023-00372-x
- By:
- Publication type:
- Article
Antipsychotic effects on anthropometric outcomes in anorexia nervosa: a retrospective chart review of hospitalized children and adolescents.
- Published in:
- Journal of Eating Disorders, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40337-023-00862-4
- By:
- Publication type:
- Article
Treatment resistance in schizophrenia: a meta-analysis of prevalence and correlates.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2023, v. 45, n. 5, p. 448, doi. 10.47626/1516-4446-2023-3126
- By:
- Publication type:
- Article
Affect Recognition, Theory of Mind, and Empathy in Preschool Children with Externalizing Behavior Problems—A Group Comparison and Developmental Psychological Consideration.
- Published in:
- Children, 2023, v. 10, n. 9, p. 1455, doi. 10.3390/children10091455
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 9, p. 2202, doi. 10.3390/pharmaceutics15092202
- By:
- Publication type:
- Article
Are informants required to obtain valid ratings on the Positive and Negative Syndrome Scale (PANSS)?
- Published in:
- Schizophrenia (2754-6993), 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41537-023-00378-5
- By:
- Publication type:
- Article
FASDetect as a machine learning-based screening app for FASD in youth with ADHD.
- Published in:
- NPJ Digital Medicine, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s41746-023-00864-1
- By:
- Publication type:
- Article
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia.
- Published in:
- CNS Drugs, 2023, v. 37, n. 7, p. 545, doi. 10.1007/s40263-023-01022-7
- By:
- Publication type:
- Article
Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, n. 7, p. 451, doi. 10.1093/ijnp/pyad029
- By:
- Publication type:
- Article
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery.
- Published in:
- BMC Psychiatry, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12888-023-04928-0
- By:
- Publication type:
- Article
Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications.
- Published in:
- Frontiers in Psychiatry, 2023, p. 01, doi. 10.3389/fpsyt.2023.1194222
- By:
- Publication type:
- Article
Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options.
- Published in:
- CNS Drugs, 2023, v. 37, n. 6, p. 499, doi. 10.1007/s40263-023-01009-4
- By:
- Publication type:
- Article
New Developments in the Treatment of Schizophrenia: An Expert Roundtable.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 5, p. 322, doi. 10.1093/ijnp/pyad011
- By:
- Publication type:
- Article
Commentary: The impact of Covid‐19 on psychopathology in children and young people worldwide – reflections on Newlove‐Delgado et al. (2023).
- Published in:
- Journal of Child Psychology, 2023, v. 64, n. 4, p. 641, doi. 10.1111/jcpp.13765
- By:
- Publication type:
- Article
Frequency and correlates of lifetime suicidal ideation and suicide attempts among consecutively hospitalized youth with anorexia nervosa and bulimia nervosa: results from a retrospective chart review.
- Published in:
- Borderline Personality Disorder & Emotion Dysregulation, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s40479-023-00216-1
- By:
- Publication type:
- Article
Association of severe mental illness and septic shock case fatality rate in patients admitted to the intensive care unit: A national population-based cohort study.
- Published in:
- PLoS Medicine, 2023, v. 19, n. 3, p. 1, doi. 10.1371/journal.pmed.1004202
- By:
- Publication type:
- Article
State of the Art of Diagnostics and Genetics in Huntington’s Chorea: Response to Dr Lange.
- Published in:
- Primary Care Companion for CNS Disorders (2155-7772), 2023, v. 25, n. 2, p. e1, doi. 10.4088/PCC.23lr03487a
- By:
- Publication type:
- Article
Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 2, p. 454, doi. 10.1093/schbul/sbac144
- By:
- Publication type:
- Article
Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies.
- Published in:
- Schizophrenia (2754-6993), 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41537-023-00334-3
- By:
- Publication type:
- Article
Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels.
- Published in:
- Acta Psychiatrica Scandinavica, 2023, v. 147, n. 1, p. 105, doi. 10.1111/acps.13515
- By:
- Publication type:
- Article
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM.
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 219, doi. 10.2147/NDT.S392351
- By:
- Publication type:
- Article
Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 1, p. 78, doi. 10.1093/schbul/sbac152
- By:
- Publication type:
- Article
Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2023, v. 13, p. 1, doi. 10.1177/20451253231211575
- By:
- Publication type:
- Article
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia.
- Published in:
- Therapeutic Advances in Psychopharmacology, 2023, v. 13, p. 1, doi. 10.1177/20451253231200258
- By:
- Publication type:
- Article
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia.
- Published in:
- Schizophrenia (2754-6993), 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41537-022-00320-1
- By:
- Publication type:
- Article
Comparing randomized controlled trials of outpatient family‐based or inpatient multimodal treatment followed by outpatient care in youth with anorexia nervosa: Differences in populations, metrics, and outcomes.
- Published in:
- European Eating Disorders Review, 2022, v. 30, n. 6, p. 693, doi. 10.1002/erv.2907
- By:
- Publication type:
- Article
Randomized controlled trial of cognitive remediation therapy in adolescent inpatients with anorexia nervosa: Neuropsychological outcomes.
- Published in:
- European Eating Disorders Review, 2022, v. 30, n. 6, p. 772, doi. 10.1002/erv.2921
- By:
- Publication type:
- Article